Covid, Novavax: “Omicron vaccine tests on men from January”

From January, the researchers of Novavax, the fifth vaccine against Covid just approved by the European agency Ema and the Italian regulatory body for the drug Aifa, will start clinical trials on men for the creation of a specific immunization for the Omicron variant. This was announced by the American company that has communicated the first data on its vaccine and on the answers obtained on Omicron.